Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "020616."
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
20MG |
| Application Number: |
N020616 |
| Product Number: |
001 |
| Approval Date: |
Jul 3, 1996 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
50MG |
| Application Number: |
N020616 |
| Product Number: |
002 |
| Approval Date: |
Jul 3, 1996 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
100MG |
| Application Number: |
N020616 |
| Product Number: |
003 |
| Approval Date: |
Jul 3, 1996 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
30MG |
| Application Number: |
N020616 |
| Product Number: |
004 |
| Approval Date: |
Mar 9, 2001 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
60MG |
| Application Number: |
N020616 |
| Product Number: |
005 |
| Approval Date: |
Mar 9, 2001 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
80MG |
| Application Number: |
N020616 |
| Product Number: |
006 |
| Approval Date: |
Oct 27, 2006 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
200MG |
| Application Number: |
N020616 |
| Product Number: |
007 |
| Approval Date: |
Feb 27, 2007 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
10MG |
| Application Number: |
N020616 |
| Product Number: |
008 |
| Approval Date: |
Apr 20, 2007 |
| Reference Listed Drug |
Yes |
| RX/OTC/DISCN: |
RX |
| TE Code: |
AB1 |
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
40MG |
| Application Number: |
N020616 |
| Product Number: |
009 |
| Approval Date: |
Jul 9, 2012 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
70MG |
| Application Number: |
N020616 |
| Product Number: |
010 |
| Approval Date: |
Jul 9, 2012 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
130MG |
| Application Number: |
N020616 |
| Product Number: |
011 |
| Approval Date: |
Jul 9, 2012 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
| Active Ingredient: |
MORPHINE SULFATE |
| Dosage Form;Route: |
CAPSULE, EXTENDED RELEASE; ORAL |
| Proprietary Name: |
KADIAN |
| Applicant: |
WATSON LABS INC |
| Strength: |
150MG |
| Application Number: |
N020616 |
| Product Number: |
012 |
| Approval Date: |
Jul 9, 2012 |
| Reference Listed Drug |
No |
| RX/OTC/DISCN: |
RX |
| TE Code: |
|
| Patent and Exclusivity Info for this product: |
View |
|
Return to Electronic Orange Book Home Page
|
FDA/Center for Drug Evaluation and Research
|
|
Office of Generic Drugs
|
|
Division of Labeling and Program Support
|
|
Update Frequency: |
|
Orange Book Data - Monthly
|
|
Generic Drug Product Information & Patent Information - Daily
|
|
Orange Book Data Updated Through May, 2013
|
|
Patent and Generic Drug Product Data Last Updated: June 19, 2013
|
-
